{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:12:04Z","timestamp":1793391124880,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","ajconline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.amjcard.2024.09.033","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T22:49:59Z","timestamp":1729291799000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Rationale and Design of OPT-RATE AF: A Randomized Clinical Trial of Increased Physiologic Pacing Rates in Heart Failure With Preserved Ejection Fraction"],"prefix":"10.1016","volume":"234","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1502-2006","authenticated-orcid":false,"given":"Evan","family":"Czulada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kolm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brototo","family":"Deb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarahfaye F.","family":"Dolman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nebu","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan A.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv A.","family":"Kabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Strouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Thomaides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2024.09.033_bib0001","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/heartjnl-2020-318081","article-title":"Update on management of atrial fibrillation in heart failure: a focus on ablation","volume":"108","author":"Mulder","year":"2022","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0002","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1161\/01.CIR.96.8.2617","article-title":"Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study","volume":"96","author":"Brignole","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0003","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.jacc.2006.05.072","article-title":"Right ventricular pacing can induce ventricular dyssynchrony in patients with atrial fibrillation after atrioventricular node ablation","volume":"48","author":"Tops","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0004","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1093\/eurheartj\/ehab569","article-title":"AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial","volume":"42","author":"Brignole","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0005","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1540-8167.2005.50062.x","article-title":"Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study)","volume":"16","author":"Doshi","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0006","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1093\/eurheartj\/ehy555","article-title":"A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS","volume":"39","author":"Brignole","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0007","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0008","doi-asserted-by":"crossref","first-page":"784","DOI":"10.7326\/0003-4819-150-11-200906020-00006","article-title":"Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure","volume":"150","author":"McAlister","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2006.07.007","article-title":"The effect of altering heart rate on ventricular function in patients with heart failure treated with beta-blockers","volume":"152","author":"Thackray","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.16598","article-title":"Association of \u03b2-blocker use with heart failure hospitalizations and cardiovascular disease mortality among patients with heart failure with a preserved ejection fraction: a secondary analysis of the TOPCAT trial","volume":"2","author":"Silverman","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0011","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/ejhf.876","article-title":"Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial","volume":"19","author":"Komajda","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0012","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2023.0675","article-title":"Rate-adaptive atrial pacing for heart failure with preserved ejection fraction: the RAPID-HF randomized clinical trial","volume":"329","author":"Reddy","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0013","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.jacc.2021.08.073","article-title":"Effect of \u03b2-blocker withdrawal on functional capacity in heart failure and preserved ejection fraction","volume":"78","author":"Palau","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0014","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/jamacardio.2023.5500","article-title":"\u03b2-blocker Withdrawal and Functional Capacity Improvement in Patients with Heart Failure with Preserved Ejection Fraction","volume":"9","author":"Palau","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/jamacardio.2022.5320","article-title":"Effect of personalized accelerated pacing on quality of life, physical activity, and atrial fibrillation in patients with preclinical and overt heart failure with preserved ejection fraction: the myPACE randomized clinical trial","volume":"8","author":"Infeld","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0016","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.amjcard.2019.07.008","article-title":"Effects of a higher heart rate on quality of life and functional capacity in patients with left ventricular diastolic dysfunction","volume":"124","author":"Wahlberg","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0017","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/eurheartj\/ehx564","article-title":"Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials","volume":"39","author":"Cleland","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0018","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007270","article-title":"Clinical outcomes after ablation of the AV junction in patients with atrial fibrillation: impact of cardiac resynchronization therapy","volume":"6","author":"Mittal","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0019","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.003993","article-title":"Mortality after atrioventricular nodal radiofrequency catheter ablation with permanent ventricular pacing in atrial fibrillation: outcomes from a controlled nonrandomized study","volume":"9","author":"Garcia","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cardfail.2018.06.009","article-title":"Safety and feasibility of a nocturnal heart rate elevation\u2014exploration of a novel treatment concept","volume":"25","author":"Yeshwant","year":"2019","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0021","doi-asserted-by":"crossref","DOI":"10.1177\/1753944719870084","article-title":"6-minute walking test: a useful tool in the management of heart failure patients","volume":"13","author":"Giannitsi","year":"2019","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0022","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1479-5868-8-115","article-title":"Validity of the International Physical Activity Questionnaire Short Form (IPAQ-SF): a systematic review","volume":"8","author":"Lee","year":"2011","journal-title":"Int J Behav Nutr Phys Act"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0023","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/CIRCOUTCOMES.115.001958","article-title":"Development and validation of a short version of the Kansas City cardiomyopathy questionnaire","volume":"8","author":"Spertus","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0024","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01823246-201324030-00004","article-title":"Clinically meaningful change estimates for the six-minute walk test and daily activity in individuals with chronic heart failure","volume":"24","author":"Shoemaker","year":"2013","journal-title":"Cardiopulm Phys Ther J"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0025","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/ejhf.2894","volume":"25","author":"Anker","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0026","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s40265-023-01887-4","article-title":"Guideline-directed medical therapy for the treatment of heart failure with reduced ejection fraction","volume":"83","author":"Patel","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0027","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(22)01429-5","article-title":"SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials","volume":"400","author":"Vaduganathan","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0028","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1093\/eurheartj\/ehad389","article-title":"Mechanisms of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction","volume":"44","author":"Pandey","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0029","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1093\/eurheartj\/ehp341","article-title":"Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure","volume":"30","author":"Wachter","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0030","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.107.716886","article-title":"Role of left ventricular stiffness in heart failure with normal ejection fraction","volume":"117","author":"Westermann","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0031","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017215","article-title":"Heart rate-induced myocardial Ca2+ retention and left ventricular volume loss in patients with heart failure with preserved ejection fraction","volume":"9","author":"Silverman","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2006.06.023","article-title":"Force- and relaxation-frequency relations in patients with diastolic heart failure","volume":"152","author":"Yamanaka","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0033","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006213","article-title":"Heart rate and heart failure with preserved ejection fraction: time to slow \u03b2-blocker use?","volume":"12","author":"Meyer","year":"2019","journal-title":"Circ Heart Failure"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0034","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1161\/CIRCULATIONAHA.106.632745","article-title":"Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction","volume":"114","author":"Borlaug","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0035","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.chest.2019.04.109","article-title":"Right ventricular-arterial uncoupling during exercise in heart failure with preserved ejection fraction","volume":"156","author":"Singh","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0036","doi-asserted-by":"crossref","first-page":"e8431","DOI":"10.1097\/MD.0000000000008431","article-title":"Heart rate and outcomes in patients with heart failure with preserved ejection fraction: a dose\u2013response meta-analysis","volume":"96","author":"Shang","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138124","article-title":"Optimal cardiac resynchronization therapy pacing rate in non-ischemic heart failure patients: a randomized crossover pilot trial","volume":"10","author":"Ghotbi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.amjcard.2024.09.033_bib0038","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.hroo.2021.11.015","article-title":"Personalized pacing for diastolic dysfunction and heart failure with preserved ejection fraction: design and rationale for the myPACE randomized controlled trial","volume":"3","author":"Infeld","year":"2022","journal-title":"Heart Rhythm"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914924007276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914924007276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T01:19:58Z","timestamp":1733620798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914924007276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":38,"alternative-id":["S0002914924007276"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2024.09.033","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and Design of OPT-RATE AF: A Randomized Clinical Trial of Increased Physiologic Pacing Rates in Heart Failure With Preserved Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2024.09.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}